T1	PROC 67 79	tratamientos
#1	AnnotatorNotes T1	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T2	DISO 92 114	infectados por COVID19
T3	PROC 169 188	evaluar la eficacia
#2	AnnotatorNotes T3	C1707887; Efficacy Study; Research Activity
T4	PROC 203 215	tratamientos
#3	AnnotatorNotes T4	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T5	PROC 255 270	hospitalización
#4	AnnotatorNotes T5	C0019993; Hospitalization; Health Care Activity
T6	DISO 303 325	infectados con COVID19
T7	PROC 402 426	consentimiento informado
#5	AnnotatorNotes T7	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T8	PROC 477 487	ingresados
#6	AnnotatorNotes T8	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T9	PROC 492 503	diagnóstico
#7	AnnotatorNotes T9	C0011900; Diagnosis; Diagnostic Procedure
T10	PROC 683 704	Saturación de oxígeno
#8	AnnotatorNotes T10	C0523807; Oxygen saturation measurement; Laboratory Procedure
T11	DISO 233 240	COVID19
#9	AnnotatorNotes T11	C5203670; COVID19 (disease); Disease or Syndrome
T12	PROC 540 551	Diagnóstico
#10	AnnotatorNotes T12	C0011900; Diagnosis; Diagnostic Procedure
T13	PROC 2589 2611	traslado a otro centro
#11	AnnotatorNotes T13	C0030704; Patient Transfer; Health Care Activity
T14	CHEM 697 704	oxígeno
#12	AnnotatorNotes T14	C0030054; oxygen; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T15	PROC 630 644	aleatorización
#13	AnnotatorNotes T15	C0034656; Randomization; Research Activity
T16	DISO 662 670	síntomas
#14	AnnotatorNotes T16	C1457887; Symptoms; Sign or Symptom
T17	PROC 790 813	métodos anticonceptivos
#15	AnnotatorNotes T17	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T18	CHEM 848 859	espermicida
#16	AnnotatorNotes T18	C0037862; Spermatocidal Agents; Pharmacologic Substance
T19	CHEM 889 900	espermicida
#17	AnnotatorNotes T19	C0037862; Spermatocidal Agents; Pharmacologic Substance
T20	CHEM 902 916	anticonceptivo
#18	AnnotatorNotes T20	C0009871; Contraceptive Agents; Pharmacologic Substance
T21	CHEM 982 996	anticonceptivo
#19	AnnotatorNotes T21	C0009871; Contraceptive Agents; Pharmacologic Substance
T22	PROC 1067 1077	vasectomía
#20	AnnotatorNotes T22	C0042387; Vasectomy; Therapeutic or Preventive Procedure
T23	PROC 1259 1277	prueba de embarazo
#21	AnnotatorNotes T23	C0032976; Pregnancy Tests; Diagnostic Procedure
T24	PROC 1383 1397	ensayo clínico
#22	AnnotatorNotes T24	C0008976; Clinical Trials; Research Activity
T25	DISO 1403 1427	infección por SARS-CoV-2
#23	AnnotatorNotes T25	C5203670; COVID19 (disease); Disease or Syndrome
T26	PROC 1431 1455	Tratamiento concomitante
#24	AnnotatorNotes T26	C1707479; Concomitant Therapy; Therapeutic or Preventive Procedure
T27	CHEM 1466 1474	fármacos
#25	AnnotatorNotes T27	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T28	PROC 1492 1504	tratamientos
#26	AnnotatorNotes T28	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T29	CHEM 1685 1697	medicamentos
#27	AnnotatorNotes T29	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T30	DISO 1726 1745	fallo multiorgánico
#28	AnnotatorNotes T30	C0026766; Multiple Organ Failure; Pathologic Function
T31	PROC 1773 1793	ventilación mecánica
#29	AnnotatorNotes T31	C0199470; Mechanical ventilation; Therapeutic or Preventive Procedure
T32	DISO 1861 1887	distrés respiratorio agudo
T33	PROC 1983 1992	screening
#30	AnnotatorNotes T33	C0220908; Screening procedure; Diagnostic Procedure
T34	PROC 1996 2022	Aclaramiento de creatinina
#31	AnnotatorNotes T34	C0373595; Creatinine clearance measurement; Laboratory Procedure
T35	PROC 2048 2057	screening
#32	AnnotatorNotes T35	C0220908; Screening procedure; Diagnostic Procedure
T36	PROC 2061 2077	Test de embarazo
#33	AnnotatorNotes T36	C0032976; Pregnancy Tests; Diagnostic Procedure
T37	PROC 2112 2121	screening
#34	AnnotatorNotes T37	C0220908; Screening procedure; Diagnostic Procedure
T38	DISO 2174 2191	hipersensibilidad
#35	AnnotatorNotes T38	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T39	CHEM 2236 2244	fármacos
#36	AnnotatorNotes T39	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T40	PROC 2261 2272	tratamiento
#37	AnnotatorNotes T40	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T41	CHEM 2290 2301	metabolitos
#38	AnnotatorNotes T41	C0870883; Metabolite; Biologically Active Substance
T42	CHEM 2304 2315	excipientes
#39	AnnotatorNotes T42	C0015237; Pharmaceutical Excipient; Biomedical or Dental Material
T43	PROC 2400 2410	evaluación
#40	AnnotatorNotes T43	C1261322; Evaluation procedure; Health Care Activity
T44	PROC 2528 2552	consentimiento informado
#41	AnnotatorNotes T44	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T45	PROC 136 163	Ensayo clínico aleatorizado
#42	AnnotatorNotes T45	C0206034; Clinical Trials, Randomized; Research Activity
T46	DISO 507 536	neumonía grave por SARS-CoV-2
T47	DISO 555 579	infección por SARS-CoV-2
#43	AnnotatorNotes T47	C5203670; COVID19 (disease); Disease or Syndrome
T48	PROC 595 598	PCR
#44	AnnotatorNotes T48	C0032520; Polymerase Chain Reaction; Molecular Biology Research Technique
T49	PROC 957 980	implante anticonceptivo
T51	PROC 1614 1644	administración del tratamiento
T52	PROC 1918 1921	ALT
#45	AnnotatorNotes T52	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T53	PROC 1924 1927	AST
#46	AnnotatorNotes T53	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T54	CHEM 2012 2022	creatinina
#47	AnnotatorNotes T54	C0010294; creatinine; Biologically Active Substance · Organic Chemical
T55	Date 12 16	2020
T56	LIVB 83 91	paciente
#48	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	LIVB 219 228	pacientes
#49	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T58	LIVB 293 302	Pacientes
#50	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T59	LIVB 430 436	Hombre
#51	AnnotatorNotes T59	C0025266; Male population group; Population Group
T60	LIVB 439 446	mujeres
#52	AnnotatorNotes T60	C0043210; Woman; Population Group
T61	Age 456 464	≥18 años
T62	LIVB 467 476	Pacientes
#53	AnnotatorNotes T62	C0030705; Patients; Patient or Disabled Group
T63	LIVB 526 536	SARS-CoV-2
#54	AnnotatorNotes T63	C5203676; SARS-CoV-2; Virus
T64	Duration 609 617	≤ 4 días
T65	Duration 671 679	≤ 4 días
T67	LIVB 724 731	hombres
#55	AnnotatorNotes T67	C0025266; Male population group; Population Group
T68	LIVB 734 741	mujeres
#56	AnnotatorNotes T68	C0043210; Woman; Population Group
T69	PHYS 746 768	capacidad reproductiva
#57	AnnotatorNotes T69	C0232896; Reproductive function; Physiologic Function
T70	DEVI 862 884	preservativo masculino
#58	AnnotatorNotes T70	C0009653; Condoms, Male; Medical Device
T71	Route 917 921	oral
#59	AnnotatorNotes T71	C1527415; Oral Route of Drug administration; Functional Concept
T73	DEVI 957 965	implante
#60	AnnotatorNotes T73	C0021102; Implants; Medical Device
T74	Route 997 1007	inyectable
T75	DEVI 1009 1033	dispositivo intrauterino
#61	AnnotatorNotes T75	C0021900; Intrauterine Devices; Medical Device
T76	Duration 1123 1134	los 30 días
T77	LIVB 1180 1187	mujeres
#62	AnnotatorNotes T77	C0043210; Woman; Population Group
T78	PHYS 1220 1242	capacidad reproductiva
#63	AnnotatorNotes T78	C0232896; Reproductive function; Physiologic Function
T79	Neg_cue 1278 1286	negativa
T80	LIVB 1346 1355	Pacientes
#64	AnnotatorNotes T80	C0030705; Patients; Patient or Disabled Group
T82	LIVB 1574 1584	SARS-CoV-2
#65	AnnotatorNotes T82	C5203676; SARS-CoV-2; Virus
T83	Duration 1588 1600	las 24 horas
T84	LIVB 1749 1758	Pacientes
#66	AnnotatorNotes T84	C0030705; Patients; Patient or Disabled Group
T85	LIVB 1824 1833	Pacientes
#67	AnnotatorNotes T85	C0030705; Patients; Patient or Disabled Group
T88	LIVB 2125 2156	Mujeres en periodo de lactancia
#68	AnnotatorNotes T88	C4316174; Patients who are breastfeeding; Patient or Disabled Group
T89	LIVB 2160 2169	Pacientes
#69	AnnotatorNotes T89	C0030705; Patients; Patient or Disabled Group
T90	LIVB 2319 2328	Pacientes
#70	AnnotatorNotes T90	C0030705; Patients; Patient or Disabled Group
T92	LIVB 2422 2434	investigador
#71	AnnotatorNotes T92	C0035173; Research Personnel; Professional or Occupational Group
T93	LIVB 2438 2445	Sujetos
#72	AnnotatorNotes T93	C0681850; Study Subject; Group
T94	Neg_cue 2450 2452	no
T95	Neg_cue 2505 2517	incapaces de
T96	LIVB 2556 2565	Pacientes
#73	AnnotatorNotes T96	C0030705; Patients; Patient or Disabled Group
T97	Duration 2615 2638	las siguientes 96 horas
T98	DEVI 834 843	diafragma
#74	AnnotatorNotes T98	C0042241; Vaginal contraceptive diaphragm (device); Medical Device
T102	PHYS 1269 1277	embarazo
#75	AnnotatorNotes T102	C0032961; Pregnancy; Organism Function
T103	PHYS 1869 1881	respiratorio
#76	AnnotatorNotes T103	C0035203; Respiration; Physiologic Function
T104	PHYS 2069 2077	embarazo
#77	AnnotatorNotes T104	C0032961; Pregnancy; Organism Function
T105	LIVB 569 579	SARS-CoV-2
#78	AnnotatorNotes T105	C5203676; SARS-CoV-2; Virus
T66	PROC 1046 1064	abstinencia sexual
#79	AnnotatorNotes T66	C2042176; abstinence from sexual contact; Therapeutic or Preventive Procedure
T72	LIVB 1417 1427	SARS-CoV-2
#80	AnnotatorNotes T72	C5203676; SARS-CoV-2; Virus
T81	PHYS 2147 2156	lactancia
#81	AnnotatorNotes T81	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T86	PHYS 2469 2479	comprender
#82	AnnotatorNotes T86	C0162340; Comprehension; Mental Process
T50	PROC 1158 1164	visita
#83	AnnotatorNotes T50	C1512346; Patient Visit; Health Care Activity
T87	Quantifier_or_Qualifier 1151 1157	última
A1	Assertion T102 Negated
A2	Status T29 History_of
A3	Assertion T86 Negated
A4	Assertion T44 Negated
A5	Status T38 History_of
A6	Assertion T39 Contraindicated
A7	Assertion T41 Contraindicated
A8	Assertion T42 Contraindicated
#85	AnnotatorNotes T2	C5203670; COVID19 (disease); Disease or Syndrome
#86	AnnotatorNotes T6	C5203670; COVID19 (disease); Disease or Syndrome
#87	AnnotatorNotes T74	C4723827; Injection Method of Administration; Functional Concept 
#88	AnnotatorNotes T32	C0035222; Respiratory Distress Syndrome, Adult; Disease or Syndrome | C0748355; Acute respiratory distress; Disease or Syndrome
T91	Neg_cue 2354 2356	no
T99	Observation 2370 2393	incluidos en el estudio
A9	Assertion T99 Negated
#84	AnnotatorNotes T99	C1302261; Patient eligible for clinical trial; Finding (?)
T100	Spec_cue 1555 1564	potencial
T101	Observation 1535 1541	acción
A10	Assertion T101 Speculated
#89	AnnotatorNotes T101	C1532643; Drug action observation; Finding
T106	Quantifier_or_Qualifier 1542 1552	demostrada
R1	Negation Arg1:T79 Arg2:T102	
R2	Speculation Arg1:T100 Arg2:T101	
R3	Negation Arg1:T91 Arg2:T99	
R4	Negation Arg1:T94 Arg2:T86	
R5	Negation Arg1:T95 Arg2:T44	
A11	Assertion T40 Contraindicated
R6	Has_Quantifier_or_Qualifier Arg1:T101 Arg2:T106	
R7	Experiences Arg1:T56 Arg2:T1	
R8	Experiences Arg1:T56 Arg2:T2	
R9	Experiences Arg1:T57 Arg2:T4	
R10	Experiences Arg1:T57 Arg2:T11	
R11	Experiences Arg1:T57 Arg2:T5	
R12	Experiences Arg1:T58 Arg2:T6	
T107	Observation 358 389	acepte participar en el estudio
R13	Overlap Arg1:T107 Arg2:T7	
R14	Has_Age Arg1:T59 Arg2:T61	
R15	Has_Age Arg1:T60 Arg2:T61	
R16	Experiences Arg1:T62 Arg2:T8	
R17	Overlap Arg1:T8 Arg2:T46	
R18	Causes Arg1:T63 Arg2:T46	
R19	Experiences Arg1:T62 Arg2:T46	
#90	AnnotatorNotes T46	C5400377; COVID-19 pneumonia aggravated; Disease or Syndrome
R20	Causes Arg1:T105 Arg2:T47	
R22	Before Arg1:T48 Arg2:T12	
R23	Overlap Arg1:T48 Arg2:T64	
R24	Before Arg1:T48 Arg2:T15	
T108	CONC 648 670	Inicio de los síntomas
R25	Before Arg1:T108 Arg2:T65	
R26	Has_Duration_or_Interval Arg1:T16 Arg2:T65	
T109	Result_or_Value 711 716	≤ 93%
R27	Has_Result_or_Value Arg1:T10 Arg2:T109	
T110	Quantifier_or_Qualifier 705 710	basal
#91	AnnotatorNotes T110	C1442488; Baseline; Quantitative Concept
R28	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T110	
R29	Experiences Arg1:T67 Arg2:T69	
R30	Experiences Arg1:T68 Arg2:T69	
R31	Experiences Arg1:T67 Arg2:T17	
R32	Experiences Arg1:T68 Arg2:T17	
T111	Quantifier_or_Qualifier 814 832	altamente eficaces
R33	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T111	
R34	Combined_with Arg1:T98 Arg2:T18	
R35	Experiences Arg1:T68 Arg2:T98	
R36	Experiences Arg1:T67 Arg2:T70	
R37	Combined_with Arg1:T70 Arg2:T19	
R38	Experiences Arg1:T68 Arg2:T20	
R39	Has_Route_or_Mode Arg1:T20 Arg2:T71	
R40	Combined_with Arg1:T20 Arg2:T49	
R41	Used_for Arg1:T73 Arg2:T49	
R42	Experiences Arg1:T67 Arg2:T21	
R43	Experiences Arg1:T68 Arg2:T21	
R44	Has_Route_or_Mode Arg1:T21 Arg2:T74	
R45	Experiences Arg1:T68 Arg2:T75	
R46	Experiences Arg1:T67 Arg2:T66	
R47	Experiences Arg1:T67 Arg2:T66	
R48	Experiences Arg1:T67 Arg2:T22	
R50	Has_Quantifier_or_Qualifier Arg1:T50 Arg2:T87	
#92	AnnotatorNotes T87	C1517741; Last; Qualitative Concept
R52	Overlap Arg1:T17 Arg2:T76	
R53	Overlap Arg1:T98 Arg2:T76	
R54	Overlap Arg1:T70 Arg2:T76	
R55	Overlap Arg1:T20 Arg2:T76	
R56	Overlap Arg1:T21 Arg2:T76	
R57	Overlap Arg1:T75 Arg2:T76	
R58	Overlap Arg1:T22 Arg2:T76	
T112	PROC 1110 1117	estudio
#93	AnnotatorNotes T112	C0008976; Clinical Trials; Research Activity
R59	Overlap Arg1:T17 Arg2:T112	
R60	Overlap Arg1:T98 Arg2:T112	
R61	Overlap Arg1:T70 Arg2:T112	
R62	Overlap Arg1:T20 Arg2:T112	
R63	Overlap Arg1:T21 Arg2:T112	
R64	Overlap Arg1:T75 Arg2:T112	
R65	Overlap Arg1:T66 Arg2:T112	
R66	Overlap Arg1:T22 Arg2:T112	
R67	Experiences Arg1:T77 Arg2:T78	
R68	Experiences Arg1:T77 Arg2:T23	
R69	Experiences Arg1:T77 Arg2:T102	
T113	CONC 1307 1316	inclusión
#94	AnnotatorNotes T113	C1512693; Inclusion; Qualitative Concept
R70	Before Arg1:T78 Arg2:T102	
R71	Overlap Arg1:T78 Arg2:T113	
R72	Overlap Arg1:T23 Arg2:T113	
R73	Overlap Arg1:T102 Arg2:T113	
T114	Observation 1356 1397	participando en algún otro ensayo clínico
R74	Experiences Arg1:T80 Arg2:T25	
R75	Causes Arg1:T72 Arg2:T25	
R76	Used_for Arg1:T27 Arg2:T26	
R77	Before Arg1:T26 Arg2:T101	
R79	Overlap Arg1:T27 Arg2:T83	
R78	Before Arg1:T27 Arg2:T51	
R80	Before Arg1:T26 Arg2:T28	
R81	Experiences Arg1:T84 Arg2:T31	
T115	CONC 1811 1820	inclusión
#95	AnnotatorNotes T115	C1512693; Inclusion; Qualitative Concept
R82	Overlap Arg1:T31 Arg2:T115	
R83	Experiences Arg1:T85 Arg2:T32	
R84	Experiences Arg1:T85 Arg2:T103	
T116	CONC 1905 1914	inclusión
#96	AnnotatorNotes T116	C1512693; Inclusion; Qualitative Concept
R86	Overlap Arg1:T32 Arg2:T116	
T117	Result_or_Value 1928 1971	>5 veces el límte superior de la normalidad
R87	Has_Result_or_Value Arg1:T52 Arg2:T117	
R88	Has_Result_or_Value Arg1:T53 Arg2:T117	
R89	Overlap Arg1:T52 Arg2:T33	
R90	Overlap Arg1:T53 Arg2:T33	
T118	Result_or_Value 2023 2036	< a 50 ml/min
R91	Has_Result_or_Value Arg1:T34 Arg2:T118	
R92	Overlap Arg1:T34 Arg2:T35	
R93	Overlap Arg1:T36 Arg2:T37	
R94	Overlap Arg1:T104 Arg2:T37	
T119	Result_or_Value 2082 2100	resultado positivo
#97	AnnotatorNotes T119	C1446409; Positive; Finding
R95	Has_Result_or_Value Arg1:T36 Arg2:T119	
R96	Overlap Arg1:T119 Arg2:T37	
R97	Experiences Arg1:T88 Arg2:T81	
R98	Experiences Arg1:T89 Arg2:T38	
R99	Causes Arg1:T39 Arg2:T38	
R100	Used_for Arg1:T39 Arg2:T40	
R101	Causes Arg1:T41 Arg2:T38	
R102	Causes Arg1:T42 Arg2:T38	
R106	Experiences Arg1:T90 Arg2:T43	
R107	Before Arg1:T43 Arg2:T99	
T120	Observation 2458 2479	capaces de comprender
A12	Assertion T120 Negated
R108	Negation Arg1:T94 Arg2:T120	
R109	Has_Quantifier_or_Qualifier Arg1:T93 Arg2:T120	
R110	Experiences Arg1:T93 Arg2:T86	
R111	Overlap Arg1:T86 Arg2:T44	
R112	Overlap Arg1:T120 Arg2:T44	
R113	Experiences Arg1:T96 Arg2:T13	
R114	Overlap Arg1:T13 Arg2:T97	
#98	AnnotatorNotes T51	C3469597; Administration of medication; Therapeutic or Preventive Procedure
#99	AnnotatorNotes T107	C1302239; Patient consented to clinical trial; Finding
R103	Experiences Arg1:T89 Arg2:T39	
R21	Overlap Arg1:T19 Arg2:T112	
R49	Experiences Arg1:T67 Arg2:T50	
R115	Experiences Arg1:T68 Arg2:T50	
R116	After Arg1:T22 Arg2:T50	
R51	After Arg1:T66 Arg2:T50	
R117	After Arg1:T75 Arg2:T50	
R118	After Arg1:T21 Arg2:T50	
R119	Overlap Arg1:T49 Arg2:T112	
R120	Overlap Arg1:T49 Arg2:T76	
R121	After Arg1:T49 Arg2:T50	
R122	After Arg1:T20 Arg2:T50	
R123	Overlap Arg1:T19 Arg2:T76	
R124	After Arg1:T19 Arg2:T50	
R125	After Arg1:T70 Arg2:T50	
R126	After Arg1:T98 Arg2:T50	
R127	After Arg1:T17 Arg2:T50	
R128	Overlap Arg1:T18 Arg2:T112	
R129	Overlap Arg1:T18 Arg2:T76	
R130	After Arg1:T18 Arg2:T50	
R85	Has_Quantifier_or_Qualifier Arg1:T90 Arg2:T99	
R104	Overlap Arg1:T66 Arg2:T76	
#100	AnnotatorNotes T120	C1273101; Ability to comprehend; Finding
#101	AnnotatorNotes T106	C0456369; Proven findings; Qualitative Concept
#102	AnnotatorNotes T49	C3687108; Placement of contraceptive implant; Therapeutic or Preventive Procedure
A13	Experiencer T56 Patient
A14	Experiencer T57 Patient
A15	Experiencer T58 Patient
A16	Experiencer T60 Patient
A17	Experiencer T59 Patient
A18	Experiencer T62 Patient
A19	Experiencer T68 Patient
A20	Experiencer T67 Patient
A21	Experiencer T77 Patient
A22	Experiencer T80 Patient
A23	Experiencer T84 Patient
A24	Experiencer T85 Patient
A25	Experiencer T88 Patient
A26	Experiencer T89 Patient
A27	Experiencer T90 Patient
A28	Experiencer T92 Other
A29	Experiencer T93 Patient
A30	Experiencer T96 Patient
A31	Status T13 Future
A32	Status T97 Future
T121	Result_or_Value 1278 1286	negativa
R105	Has_Result_or_Value Arg1:T23 Arg2:T121	
